Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Human papillomavirus as a risk factor for development of cancer in allograft recipients

P Fiedor, Z Wierzbicki, K Pawelec, T Łazowski, A Gardyszewska, P Jurkowski, D Szubińska, K Szymańska, J Wojciula, A Wydrzyńska, M Socha, G Kowalska-Korczak, A Górski, M Durlik, L Pączek, S Majewski

Ann Transplant 2009; 14(1): 24-24 :: ID: 880286


Background: Human papillomavirus (HPV) infection is the most common person-to-person transmitted viral infection and has a steadily increasing prevalence. The goal of this study was to evaluate the incidence of oncogenic type 16 HPV infections and development of cancer in patients after organ allotransplantation.
Material/Methods: 650 organ allograft recipients [kidney, kidney-pancreas, liver] transplanted between 1989 and 2003, receiving standard immunosuppressive treatment (CS, CsA, Tac and Aza), were followed for 2-15 years. Activity of specific receptors and mononuclear cells from peripheral blood was assessed and correlated with level of immunosuppression regiments. All patients were examined for the presence of HPV infection (confirmed by PCR).
Results: In 136 patients HPV16 oncogenic infection was found. Out of this number, in 22 patients (16.6%) skin and/or mucosal changes in anogenital area were found. Those patients were surgically treated and the diagnosis of cancer was confirmed by histopathology. The same type 16 of HPV was detected in the oral cavities. All recipients with clinical manifestation of HPV infection including patients with cancer showed abnormality and particularly lower activity of NK, CD4 and CD25 cell receptors. Immunosuppressive treatment was modified in these patients. Recurrence of cancer was observed in three patients 2-5 years after surgical treatment.
Conclusions: Long-term surviving organ allograft recipients with decreased
immune response and HPV infection have a high risk of neoplastic process
development in lower genital tract. Such patients should be carefully monitored and when such complication occurs surgical treatment is necessary with modification of immunosuppressive treatment.

Keywords: viral infections


In Press

06 May 2022 : Original article  

Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...

Ann Transplant In Press; DOI: 10.12659/AOT.936293  

27 Apr 2022 : Review article  

A Systematic Review of the Literature on Chronic Kidney Disease Following Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.935170  

Most Viewed Current Articles

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358